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The RNA interference technique is a powerful tool to understand gene function. Intriguingly, RNA interference cannot only be used for
cells in vitro, but also in living organisms. Here, we have adapted the method for use in the chick embryo. However, this technique is limited
by the uncertainty in predicting the RNAi transfection efficiency and site in the embryo. Hence, we elaborated a modified vector system,
pEGFP–shRNA, which can coexpress enhanced green fluorescent protein (EGFP) and short hairpin RNA (shRNA) simultaneously to
facilitate analysis of gene silencing in chicken embryos. We tested the silencing of two highly conserved genes (cAxin2, cParaxis), which
play crucial roles in chicken embryonic developmental processes. For each target gene, four to five small DNA inserts, each of them
encoding one shRNA, were selected and cloned individually to the vector downstream of the Pol III promoter (either human H1 or U6
promoter), which shared with highly conserved motifs in human and chicken. The pEGFP–shRNA constructs were electroporated into the
neural tube or somites. After subsequent re-incubation of 24 h, the EGFP expression, with green fluorescent signal, indicated the transfected
regions in the neural tube or somites. The EGFP expressing embryos were further submitted into the process of in situ hybridization for
examination of the silencing effects. The results show that the EGFP signal in transfected areas correlated with the silencing of the target
genes (cAxin2, cParaxis). The cAxin2 expression was inhibited by shRNAs of either targeting the RGS domain or the DAX domain coding
region. The cParaxis mRNA level in transgenic somites and the related migratory myogenic population was also reduced. The results suggest
that our novel dual expression EGFP–shRNA system opens a new possibility to study gene function in a convenient and efficient way.
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During embryonic development, a tight control of
activation and inactivation of the newly formed genome is
the prerequisite of cell proliferation, growth, differentiation,
pattern formation, and morphogenesis. This becomes man-
ifest by dynamic gene expression patterns, which specify
where andwhen particular genes are expressed in the embryo.
In vertebrates, certain genes are expressed during embryonic
development in a time- and tissue-specific manner. Axin2 is0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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is expressed in Hensen’s node, primitive streak, tail bud,
neural tube, dermomyotome, dorso-medial lips of somites,
limb buds, AER, and brain. As a DAX domain containing
protein, Axin activates the mitogen-activated protein kinase
JNK via distinct mechanisms (Wong et al., 2004). As an RGS
domain containing and nuclear–cytoplasmic shuttling pro-
tein, Axin mediates the degradation of beta-catenin, a key
effector of the canonical Wnt signaling pathway, which
regulates many aspects of embryonic development (Cong and
Varmus, 2004). Paraxis is a basic helix–loop–helix tran-
scription factor which is expressed in the paraxial mesoderm
and somites. Paraxis regulates morphogenesis of the somites
that have a central role in the patterning of the axial skeleton
and skeletal muscles (Burgess et al., 1995; Sosic et al., 1997).
In mice homozygous for a Paraxis null mutation, cells from285 (2005) 80 – 90
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somite formation is disrupted as a consequence (Burgess et
al., 1996).
Regulating or reprogramming of gene expression patterns
has a crucial role in embryonic development (Reik et al.,
2001). The recent discoveries of RNA interference and
related RNA silencing pathways have revolutionized our
understanding of gene regulation. The dsRNA-processing
enzyme Dicer was found to produce short interfering RNAs
(siRNAs), which induce sequence-specific gene silencing.
The natural short hairpin dsRNAs (termed as microRNAs or
miRNAs) have been described, which link the RNAi
machinery to a natural developmental gene regulatory
mechanism, involved in developmental timing, cell death,
cell proliferation, and cell fate (Ambros, 2004). In fact, the
lin-4 and let-7, microRNA genes, were first cloned on the
basis of their mutant phenotypes, and the genes were found to
encode (21–22 nucleotides) RNAs that are non-coding for
any proteins (Lee et al., 1993; Reinhart et al., 2000). A defect
of microRNA genes in mice accounted for the developmental
phenotypes associated with disruption of the RNAi pathway
(Bernstein et al., 2003). Now abundant non-coding RNAs
were found from C. elegans to humans (Lim et al., 2003;
Lewis et al., 2003; Bartel, 2004). In the draft of the chicken
genome, 121 microRNAs were predicted and reported
(Hillier et al., 2004).
RNAi is a remarkable process whereby small non-coding
RNAs silence specific genes. The discovery of the endoge-
nous microRNAs in the form of small temporal RNAs as
triggers of the RNAi pathway suggested that exogenous RNA
triggers might induce RNAi in animal cells too. The vector-
based shRNAs with hairpins ranging from 19 to 29
nucleotide base pairs in length, and with the degrees of
structural similarity to natural microRNAs, can be designed
based on target gene sequences (Brummelkamp et al., 2002;
Khvorova et al., 2003). Synthetic siRNAs, which are similar
to the products of Dicer, were shown to induce sequence-
specific gene silencing in human cells without initiating non-
specific gene silencing (Elbashir et al., 2001). More recently,
the RNAi machinery was linked to silencing of chromatin
regulation (Volpe et al., 2002; Lee et al., 2004). The success in
using RNAi for analyzing single genes has led to efforts to
apply this approach on a large scale for functional genomics.
A custom microarray platform for analysis of microRNA
gene expression is initiated and available. The microRNA
expression patterns from different embryonic stages, em-
bryonic stem cells, and embryoid bodies were examined
(Thomson et al., 2004). Recently, also, methods have been
described for constructing shRNA libraries based on mani-
pulation of complementary DNA or genomic DNA (Paddison
et al., 2004; Sen et al., 2004). However, some gene functions,
particularly those related to development and disease may
be difficult to be identified without experiments in vivo.
After the genomes of several species were assembled, the
gene sequences of interest are available. RNAi, harnessed as
an experimental tool, has revolutionized approaches todecode gene function (Hannon and Rossi, 2004). Vector-
based shRNAs have been tested to interfere with specific
target genes in chicken embryos (Pekarik et al., 2003;
Katahira and Nakamura, 2003; Chesnutt and Lee, 2004).
With the development of vector-based shRNA as a tool for
specific gene silencing, the chicken embryo may become an
efficient in vivo model system to study gene function during
embryonic development. This approach will be one of the
valuable tools for functional genomics. However, before
shRNA could be harnessed as an efficient experimental tool
for silencing specific genes in chicken embryos in vivo, we
are facing considerable questions. First, we want to know
whether the human U6 promoter or H1 promoter can drive
shRNA synthesis in chicken embryos, although it has been
reported that this is the case for the mouse U6 promoter
(Katahira and Nakamura, 2003). Secondly, when trying to
apply exogenous shRNA to trigger silencing of target genes
in vivo, it is difficult to identify transgenic cells or tissue in
embryos without the coexpression of a reporter gene. In order
to meet these challenges, we developed a human Pol III
promoter driven shRNA and SV40 promoter driven EGFP
coexpression system, and tested the constructs in the chicken
embryo model to generate a somatic loss-of-function
approach for the chicken Axin2 (cAxin2) and chickenParaxis
(cParaxis) genes.Materials and methods
Analysis of target genes for shRNA selection
To find shRNA target sites in the mRNAs of cAxin2
(NM_204491) and cParaxis (NM_204946) genes, the
coding sequences of genes were analyzed online with
pSilenceri Expression Vectors Insert Design Tool, which
were provided by Ambion company (www.ambion.com).
The program scanned the sequences, and indicated each
position of the AA dinucleotides, and the following 19 base
target oligonucleotides. The candidate shRNAs were sub-
jected for BLAST analysis on Genbank from NCBI server
(www.ncbi.nlm.nih.gov/BLAST). Four to five candidate
siRNAs for each target gene were selected. As shRNA
DNA template and plasmid insert, the loop sequence
(TTCAAGAGA) between the corresponding sense and
antisense siRNA oligonucleotides; poly T, and overhangs
for cloning were added as outlined in the pSilencer
siRNA expression vectors’ Instruction Manuals from
Ambion. The designed DNA oligonucleotides were
ordered from Invitrogen.
Construction of pEGFP–shRNA plasmid
The pSilencer 3.0-H1 and the 2.0-U6 siRNA expression
vectors were provided by Ambion. Each pSilencer Vector
has an RNA polymerase III (Pol III) promoter, ampicillin
resistance gene, and E. coli origin of replication. Both
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leave overhangs that facilitate directional cloning; and 1
DNA Annealing solution was prepared for annealing the
DNA oligonucleotides as an insert for ligation.
The selected siRNA inserts for the gene silencing were
subcloned into the pSilencer3.0-H1 vector. For comparing
the efficacy of H1 promoter and U6 promoter to drive
shRNA synthesis in chicken embryos, the same selected
siRNA inserts for cAxin2 gene silencing were not only
subcloned into the pSilencer 3.0-H1, but also subcloned into
the pSilencer 2.0-U6, as these two kinds of vectors shared
the same overhangs as the siRNA inserts at the 5Vand 3Vend
of the DNA with BamHI and HindIII restriction sites. After
ligation, the plasmids with inserts were confirmed by
sequencing (MWG Biotech) with the primer (5V
CGGGCCTCTTCGCTATTACG 3V), which is shared by
these two vectors. The circular, negative control pSilencer
vector that expresses a siRNAwith limited homology to any
known sequences was designed and provided by Ambion.
To further construct the pEGFP and shRNA coexpression
system, we took the fragments from shRNA insert contain-
ing pSilencer 3.0-H1 or 2.0-U6 plasmids by restriction with
KasI and AlwNI. The fragments contained H1 or U6
promoter, shRNA sense, loop, antisense, and 6 T termi-
nation sequence as RNA pol III terminator. These fragments
were then reorganized into a modified green fluorescent
protein expression vector with extra KasI restriction site at
the end of E. coli origin of replication. The vector was
modified on the base of pCMS-EGFP vector (BD Bio-
sciences), which contains SV40 promoter, enhanced green
fluorescent protein gene (EGFP), ampicillin resistance gene,
and E. coli origin of replication.
In ovo electroporation
Fertilized eggs of Gallus gallus (White Leghorn) were
incubated at 38-C and 80% relative humidity for the
required time period to obtain stages 17–18 HH. The stages
of embryos were determined according to Hamburger and
Hamilton (1951). The upper side of the eggs were
windowed to visualize the embryos, the extra membrane
were partially removed. The pEGFP–shRNA constructs
(2–3 Ag/Al) are dissolved in an adjunct solution (50 Al
stock solution: 25 Al carboxymethlycellulose, 7.5 Al fast
green, 3.0 Al MgCl2, 7.5 Al 20 PBS, and 7.0 Al H2O) in a
ratio of 2:1. The DNA constructs were microinjected into
the target neural tube or somites, and electroporated as
previously described (Mann et al., 2003; Scherr et al.,
2003). The electrodes were placed at each side of the
microinjected embryo, and five square pulses of 30–55 V,
20-ms width was applied for each embryo. Upon passing
current, the plasmid DNAs with negative charges were sent
to the cells or tissues adjacent to the anode side. After 24-h
re-incubation, the EGFP expression in the transgenic
embryos was visualized under fluorescence microscopy
and photographed.In situ hybridization
The EGFP expressing embryos were fixed overnight in
4% paraformaldehyde at 4-C, and then passed through
graded series of methanol dehydration and stored at 20-C.
Whole mount in situ hybridization with a probe against the
target gene was performed as previously described (Nieto et
al., 1996). As a template for riboprobe preparation to detect
cAxin2 gene expression, the cAxin2 coding sequence was
used. Probe for cParaxis was prepared from cParaxis gene
coding region. All of the probes were labeled with
digoxigenin RNA labeling kit (Roche). Alkaline phospha-
tase conjugated anti-DIG (Roche), with the color substrates
4-nitroblue tetrazolium chloride (NBT) and 5-bromo-4-
chloro-3-indolyl-phosphate (BCIP), was used for detection
of target gene expression signals. The chicken embryos
displaying a restricted expression pattern of the target gene
were photographed again. The images from the whole
mount in situ hybridization were analyzed, comparing with
the EGFP signals from the same transgenic embryos.Results
Homologous sequences of U6 and H1 promoters
High rates of pol III transcription of RNA genes are
necessary for cells to sustain growth. The well-characterized
promoters of RNA genes transcribed by RNA polymerase III
are from the human H1 and U6 RNAs (Myslinski et al., 2001;
Stunkel et al., 1997). Both U6 and H1 RNA genes are
involved in regulation of post-transcription processes. The
U6 RNA links to the function of spliceosomes, which
catalyze removal of the non-coding intron from a pre-mRNA.
H1 RNA is the RNA component of human Ribonuclease P
(RNase P), which cleaves the 5V end of precursor tRNA
(Mann et al., 2003). The DNA elements of the human H1 or
U6 RNA promoters both contain the distal sequence element
(DSE), proximal sequence element (PSE), and TATA motifs
(Myslinski et al., 2001; Stunkel et al., 1997). The PSE
together with the TATA box determines the assembly of a pol
III-specific pre-initiation complex for RNA gene transcrip-
tion (Cabart and Murphy, 2001). After the draft genomes of
human, chimpanzee, and mouse were assembled, the draft
genome sequence of the red jungle fowl, G. gallus, was
presented recently in Nature. Within the draft chicken
genome, a total of 15 copies of U6 RNA genes and 1 copy
of RNase P RNA gene were identified (Hillier et al., 2004).
The comparison of chicken sequences with the sequences of
human and the other species may provide high specificity in
predicting functional elements. Here, we compared the
homologous sequences of human U6 and H1 promoters
from human, chimpanzee, mouse, rat, and chicken. All of the
U6 RNA promoters contain the DSE, PSE, and TATAmotifs.
All the species share the sequences of TTTGCA in the DSE
motif, CC in the PSE motif, and a TATA box in TATA motif.
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promoter sequences also contain the DSE, PSE and TATA
box motifs. However, they are organized in a more compact
way (the 5V-flanking region between around 100 and 1)
than in U6 promoters (the 5V-flanking region between around
200 and1). Furthermore, the sequences in the DSE motif
of H1 or H1-like promoters are relatively similar. Human and
chimpanzee share the sequence of ATTTGCA, chicken has
one point mutation A in its DSE motif resulting in the
sequence ATTAGCA. However, mouse and rat have only
four identical residues TGCA in the forward orientationFig. 1. Motif analysis of human RNase P (H1) RNA or U6 RNA promoter homo
chicken genomes (all of the sequences located in genomes were indicated). Both R
the compared species. (a) Alignment of RNase P (H1) RNA gene promoters: In D
has one point mutation as the sequence of TTAGCA; rat and mouse have the reve
codon of human H1 RNA gene was ATA. (b) Alignment of U6 RNA gene promot
TTTGCA. The start codon of human U6 RNA gene was GTG.sequence (ATGCAAA) of their DSE motifs (or the identical
residues if their DSE motif sequences are in the reverse
orientation) to human, chimpanzee, and chicken. So,
compared with human U6 and H1 promoters, chicken has
the DNA elements for Pol III to transcript RNA genes in its
homologous sequences (Fig. 1).
Vector-based shRNA and EGFP coexpression system
With developmental application of RNAi techniques
on chicken embryos in vivo, we tried to build up a vector-logous sequences from the assembled human, chimpanzee, mouse, rat, and
Nase P (H1) and U6 promoters contain DSE, PSE, and TATA motifs in all of
SE motifs, human and chimpanzee have the sequence of TTTGCA; chicken
rse sequences, compared with consensus sequence of DSE motif. The start
ers: All the species have highly conserved DSE motifs with the sequence of
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propose, we took two genes related to development, cAxin2
(NM_204491) and cParaxis (NM_204946), which we
are familiar with, for these experiments. These two genes
have different molecular characteristics and gene functions,
as well as specific gene expression patterns in chicken
embryos.
To find efficient shRNAs for silencing of target genes of
interest, the coding sequences of cAxin2 (2514 bp) and
cParaxis (552 bp), from the beginning with the AUG start
codon of the transcript to the stop codon, were scanned with
pSilenceri Expression Vectors Insert Design Tool fromFig. 2. Analysis of target genes (cParaxis and cAxin2) and selected shRNAs for si
against 5Vend (157) and bHLH domain coding region (272, 286, 295) of the cPara
(319, 390, and 420), or the DAX domain coding region (2120, 2400) of cAxin2Ambion. For gene silencing, double AA plus the 3Vadjacent
19 nucleotides represented one of the potential shRNA
target binding sites. siRNAs with 3V overhanging UU
dinucleotides were reported to be the most effective
(Elbashir et al., 2001). We have analyzed the candidate
shRNAs with BLAST based on Genbank to know the
contiguous base pairs of homology to other genes. We have
noticed that the suggestion on shRNAs sequence conditions
for effective gene silencing in mammalian cells and in ovo
RNAi using chicken embryos. It included the G/C at the 5V
end of the sense strand; A/U at the 5Vend of the antisense
strand; at least five A/U residues in the 5V terminal of thelencing the target genes are indicated by diagrams. (a) Selected shRNAs are
xis mRNA. (b) Selected shRNAs are against the RGS domain coding region
mRNA.
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than 9 nt in length (Ui-Tei et al., 2004). Therefore, to
interfere with cParaxis, we selected four DNA oligonucleo-
tides as shRNA templates (the oligonucleotides of the sense
strands begin at positions 157, 272, 286, and 295 from the
start codon AUG) (Fig. 2a). To interfere with the cAxin2
gene, we selected three DNA oligonucleotides from the
cAxin2 RGS domain coding region (the oligonucleotides of
the sense strands begin at positions 319, 390, and 420 nt
from the start codon AUG), and two oligonucleotides from
cAxin2 DAX domain coding region (the oligonucleotides of
the sense strands begin at positions 2120 and 2400 nt from
the start codon AUG) (Fig. 2b). The potential target sites
were compared to the gene database and the homologies of
selected shRNAs for cAxin2 were fewer than 16 nt
contiguous base pairs to the other genes, even to chicken
Axin1 (AY687628 and AY640375).
The selected DNA inserts were first ligated into the
pSilencer 3.0-H1 or pSilencer 2.0-U6 vectors and sequenced
with expected results. However, when we applied those
vector-based shRNA to chicken embryos, we found that it
was difficult to identify the transgenic cells or tissue after
the plasmid delivering and re-incubation of those embryos.
This led us to design the vector-based EGFP and shRNAFig. 3. Plasmid backbones were designed for construction of pEGFP-U6-shRN
sequence of a sample template (shRNA 420 for silencing cAxin2 gene). Both plas
and poly A. Both plasmids have the insert as DNA template elements for shRNA: s
but with different Pol III promoters: human H1 RNA promoter (left plasmid diag
diagram). Both kinds of the plasmids are designed to synthesis of same shRNA wcoexpression system to overcome this obstacle. As EGFP
expression vector, pCMS-EGFP shared the sequence of
ColE1 origin with the vectors pSilencer 3.0-H1 or pSilencer
2.0-U6. This gave us a chance to harvest the fragments from
the insert containing pSilencer 3.0-H1 or pSilencer 2.0-U6
plasmid by double restriction with enzymes AlwNI and
KasI. The one kind of harvested fragments from constructed
pSilencer 3.0-H1 plasmids contained the elements of KasI
restriction site, H1 promoter, sense, loop, antisense, poly
(T), partial 3V ColE1 origin, and AlwNI restriction site
sequences. The other kind of fragments from constructed
pSilencer 2.0-U6 plasmids contained the same elements, but
with U6 promoter in the opposite orientation (Fig. 3). The
fragments were inserted into a modified EGFP expression
vector. The plasmids with both shRNA and EGFP coex-
pression elements have three HindIII restriction sites, and
can be digested into three DNA fragments (415 bp, 1621 bp,
and 3884 bp) after restriction with enzyme HindIII.
EGFP expression indicates the transgenic cells and tissue of
the embryos
In ovo electroporation to deliver the plasmid DNA into
chicken embryos was reported as an efficient gene trans-A and pEGFP-H1-shRNA plasmids. The diagram shows the design and
mids contain EGFP gene expression elements: SV40 promoter, EGFP gene,
ense, loop, antisense, and poly T as RNA pol III terminator (top backbones),
ram) or human U6 RNA promoter with the other orientation (right plasmid
ith 19 base pair (bottom box).
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mura, 2003; Chesnutt and Lee, 2004; Krull, 2004; Scaal et
al., 2004). We have used this method to send an EGFP
expression plasmid, pCMS-EGFP, at a final concentration of
1–2 Ag/Al to the neural tube or somites, respectively. Upon
passing the current via electroporation, the plasmid DNAs
with negative charges were mainly moving into the cells or
tissues adjacent to the anode. After the operations and 24-h
re-incubation, the embryos were checked under fluores-
cence microscopy. As expected, the EGFP was expressed
both in the sites of transgenic neural tube and somites (Fig.
4). For RNAi of the target genes, cAxin2 and cParaxis, we
used our constructed EGFP–shRNA coexpression plasmids
at the final concentration of 1–2 Ag/Al for gene transfection
into the chicken embryos. As cAxin2 gene is mainly
expressed in the neural tube and cParaxis gene is strongly
expressed in the somites at stages 17–18 HH of chicken
embryos, we aimed our constructed plasmids, pEGFP-
cAxin2-shRNAs, at the neural tubes, and the plasmids,
pEGFP-cParaxis-shRNAs at the somites.
Target gene silencing in the indicated region with EGFP
expression
As the cAxin2 gene is more than 2.5 kb long, we tested the
cAxin2 gene silencing with our constructed pEGFP-cAxin2-
shRNA plasmids to target in the area of the RGS coding
region or DAX domain of the cAxin2 gene, separately. AfterFig. 4. EGFP gene was expressed in the transgenic neural tubes and somites of chic
pEGFP-U6, but without shRNA template). Diagram of in ovo electroporation. The
neural tube of chicken embryos as illustrated in panel a. EGFP gene was expressed
the same embryo, cParaxis gene was expressed as wild type in somites in panel c.
with pEGFP-H1 control plasmid in panel d, or with pEGFP-U6 control plasmid
transgenic neural tubes in panels e and g. Scale bar: in panel b, 0.1 cm for panels b
and g.electroporation of the plasmids into the neural tubes and 24 h
of re-incubation, the green fluorescent signal from EGFP
expression of all plasmids indicated the transgenic sites in the
neural tubes. The whole mount in situ hybridization, using
cAxin2 gene-specific antisense probe, was used to check
whether cAxin2 expression was inhibited or not. We found
that the cAxin2 gene expression only in the transgenic sites of
neural tubes was inhibited. The inhibition effect was achieved
either by targeting on the RGS domain coding region (at the
positions of 319, 390, 420), or on the DAX domain coding
region (at positions of 2120, 2400) of cAxin2. Moreover, the
silencing effects of cAxin2 were achieved by shRNAs driven
by either H1 promoter or U6 promoter. As wild-type cParaxis
is mainly expressed in the somites, we electroporated the four
mixed pEGFP-cParaxis-shRNAs into somites. After 24 h of
re-incubation, we observed a decreased gene expression level
of cParaxis in transgenic somites and the migratory
myogenic population (Fig. 5). Comparison of the images of
EGFP expression and silencing of cAxin2 or cParaxis in the
transgenic tissues showed that EGFP expression could
indicate perfectly well the transgenic cells and tissue with
the target gene RNAi in the chicken embryos. Additionally,
we also analyzed for specificity of our silencing constructs by
electroporating shRNA targeted against cAxin2 in the neural
tubes and checked for cPax3 and cCXCR4, which are also
expressed in the neural tube. The expression pattern of both
cPax3 and cCXCR4 were not affected after interference with
shRNA targeting cAxin2 (data not shown).ken embryos after in ovo electroporation of control plasmids (pEGFP-H1 or
EGFP expressing plasmid can be injected and electroporated into somites or
in somites after transfection with pEGFP-H1 control plasmid in panel b. In
EGFP gene was expressed in neural tubes after the gene transfection either
in panel f. The cAxin2 gene was expressed as wild type in the area of the
and c; in panel d, 0.1 cm for panels d and e; in panel f, 0.1 cm for panels f
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Recently, RNAi as an experimental tool has revolution-
ized approaches to understand gene function. Exogenous
dsRNA, siRNA, and shRNA can silence specific target
genes. In the cell, long dsRNAs are cleaved into small
interfering RNAs (siRNAs), by a ribonuclease Dicer. The
siRNAs subsequently assemble with protein components
into an RNA-induced silencing complex (RISC), and cause
unwinding in the process. Activated RISC then binds to
complementary mRNA by base pairing interactions between
the siRNA antisense strand and the target mRNA. The bound
target mRNA is cleaved and sequence-specific degradation
of mRNA results in target gene silencing. In mammalian
cells, introduction of long dsRNA (>30 nt) may initiate a
potent antiviral response. Although RNAi silences gene
expression in a sequence-specific manner, several recent
studies have suggested that the specificity of silencing is not
absolute (Hannon and Rossi, 2004; Clayton, 2004). Long
dsRNA could be cut to produce several tens of small RNAi,
some of them may nonspecifically target the other genes
which share similar sequences. The efficiency and specificity
of RNAi depend on the position and sequence of the shRNA
used. The nonspecific response may be reduced by the
introduction or expression of siRNAs. Based on the cParaxis
gene coding sequence, about a dozen of shRNA probes are
listed as candidates to target cParaxis. They may also be the
siRNA products of the long dsRNA in vivo. We tested four
shRNA probes (p157, p272, p286, p295) for targeting the
cParaxis mRNA. The cParaxis gene expression was
reduced in the transgenic area of the somites, and the related
migrating cells in the limb bud. cParaxis belongs to the basic
helix–loop–helix (bHLH) transcription factor family, in
which several genes share a similar sequence in the bHLH
coding region. A similar gene is also expressed in somites,
cScleraxis, the sequence of which is nearly identical toFig. 5. Comparison of EGFP gene expression and target gene silencing in
the same transgenic embryos with coexpressing pEGFP–shRNA plasmids.
In the transgenic neural tube with EGFP gene expression in panel a, the
cAxin2 gene expression was interfered, red arrows in panel b, the shRNA
synthesis were driven by U6 promoter, and the shRNA binding sites were
selected around RGS domain. The EGFP gene was expressed in neural tube
in panel c, the cAxin2 gene expression was inhibited, indicated by red
arrows in panel d, the shRNA synthesis was driven also by U6 promoter,
but the shRNA binding sites were against the DAX domain. The EGFP
gene was expressed in neural tube in panel e, the cAxin2 gene expression
was down-regulated shown by red arrows in panel f, the shRNA synthesis
was driven by H1 promoter, the shRNA binding sites were against the RGS
domain. The EGFP gene was expressed in neural tube in panel g, the
cAxin2 gene expression was inhibited, red arrows in panel h, the shRNA
driven by H1 promoter, but the shRNA binding sites were against the DAX
domain. In the transgenic somites with EGFP gene expression in panel i,
the cParaxis gene expression was interfered, indicated by red arrows in
panel j, the shRNA synthesis was driven by H1 promoter, and the shRNA
binding sites were against regions lying before and in the bHLH domain.
Scale bar: in panel a, 0.1 cm for panels a and b; in panel c, 0.1 cm for panels
c and d; in panel e, 0.1 cm for panels e and f; in panel g, 0.1 cm for panels g
and h; in panel i, 0.1 cm for panels i and j.cParaxis within the bHLH region but diverges in its amino
and carboxyl termini (Burgess et al., 1995, 1996; Sosic et al.,
1997). As previously reported by Ambion, typically more
than half of randomly designed siRNAs provide at least a
50% reduction in target mRNA levels and approximately 1
F. Dai et al. / Developmental Biology 285 (2005) 80–9088of 4 siRNAs provides a 75–95% reduction. Multiple
applications of shRNAs may result in relatively high
silencing efficiency. In this study, we tested two or four
mixed shRNAs to silence target genes. Based on BLAST
analysis of the gene database, we find that the supposed
shRNAs for silencing cParaxis, p157, p272, p286, and p295,
are completely complementary to cParaxis. When we
eletroporated these shRNA constructs precisely to cParaxis
expressing cells in somites at particular times and locations,
the expression of cParaxis could be inhibited. However, the
shRNA p286 may interfere with cScleraxis (18 nt/19 nt),
cNeuroD (17 nt/19 nt); and the shRNA p295 may silence
cScleraxis (18 nt/19 nt), cNeuroD (18 nt/19 nt), and
cNeurogenin2 (17 nt/19 nt). As we have known, the
cNeuroD gene is mainly expressed in the neural tube,
cParaxis and cScleraxis are normally expressed in the
somites. The exact location of expression further depends on
the stage of development. cParaxis expression declines soon
after sclerotome formation, whereas cScleraxis expression
increases in the sclerotome and its derivatives (Burgess et al.,
1995). A variety of morphological effects can be expected
depending on the time and site of shRNA vector
administration. In the in vivo model, we may maximally
reduce nonspecific interference of target genes as its
expression is time-dependent and tissue-specific during
embryonic development.
After the genomes of several species (human, chimpanzee,
mouse, rat, and chicken) were assembled, identification of the
gene function and gene expression regulation patterns
became a major task. From the draft chicken genome data,
about one billion DNA base pairs, the chicken genome is only
one-third the size of the human genome, but it contains
20,000 to 23,000 genes (Hillier et al., 2004). The genes are
expressed in a strictly controlled spatio-temporal pattern
during the period of embryonic development. Many of these
developmental control genes are also expressed during
pathological processes. cAxin2, for example, is mainly
expressed in the neural tube, and the limb buds, but cParaxis
is strongly expressed in the somites of embryos. To under-
stand the gene function, in vivo experiments are indispen-
sable. Chicken embryos serve as a good model for research in
functional genomics for several reasons: First, it is easy to be
handled and accessible to microsurgical manipulation.
Secondly, many chicken genes, like cAxin2 and cParaxis,
are very similar to human genes. In this study, we have used
the human H1 promoter and the human U6 promoter to drive
the shRNA for silencing chicken target genes. The results
showed that both human H1 and U6 promoter could drive
shRNA synthesis in transgenic chicken embryos. Thirdly,
compared with the creation of gene knockouts in mice, which
can take up to several months, RNAi in chicken embryos can
potentially produce answers within days or weeks (Clayton et
al., 2004). For some important genes, the generation of
knockout mice encounters severe problems due to early
embryonic lethality or problems in the construction of
homologous recombinants, requiring additional strategies.Alternatively, the techniques of transgenic RNAi were also
successfully applied in mouse embryos (Stein et al., 2003;
Svoboda et al., 2004).
The chicken embryo has been long used to study gene
activity and disorders. After the chicken genome was
assembled, the chicken may provide a good model for
studying changes in genes linked to diseases like muscular
dystrophy, viral infection, aging, and death. Knowledge of
chicken gene function will lead to insights into human
biology andmedicine. RNAi and chicken embryo model may
be useful for some related research on human disease. In a
remarkably short time since the discovery of RNAi, it has
emerged as a powerful tool for the study of gene function.
With the increasing use of RNAi in vivo, RNAi has been
proposed as a research tool and a potential treatment for
human diseases, like cancer, or viral infections. Using RNAi
to target genes expressing oncogenic fusion proteins, such as
the Bcr-Abl oncoprotein p210 that is characteristic of chronic
myelogenous leukemia (CML), has provided excellent proof
of principle for RNAi as a therapeutic anti-cancer agent
(Scherr et al., 2003). RNAi has been used to target several
early and late HIV-encoded RNAs in cell lines and in primary
hematopoietic cells (Jacque et al., 2002). Furthermore,
hepatitis viruses, like hepatitis B virus (HBV) and hepatitis
C virus (HCV), have also been the important targets for
potential RNAi therapy. The study reported that significant
interference with the HBVand HCV could be achieved by the
shRNA (McCaffrey et al., 2003; Kapadia et al., 2003).
However, the delivering efficiency of shRNA to infected cells
or tissues with disease caused by virus still needsmore in vivo
research data before clinical studies can begin. On the other
hand, chicken embryos can be infected easily by retroviruses,
including overexpression of genes of interest by an exper-
imental model of avian retrovirus overexpression system
(RCAS and RCASBP) (Hu et al., 2004). The shRNA and
chicken embryo model may be a valuable tool to test RNAi to
inhibit viral gene expression and viral replication. Addition-
ally, our pEGFP–shRNA coexpression system, using the
human H1 promoter or the human U6 promoter, can be
optimally used for human cells or human cancer cell lines for
screening disease-related genes.
The key challenge for achieving effective RNAi in vivo
is its delivery to the desired organ and into the target cells, to
ensure specificity and adequate dose. The advantages of
using a vector-based EGFP–shRNA coexpression system
may make it a more convenient and efficient way to target
genes by shRNA-induced silencing in the chicken embryo
by in ovo electroporation. Our pEGFP–shRNA vector
contains an RNA polymerase III (Pol III) promoter and
EGFP expression elements. We use shRNA instead of
dsRNA to limit nonspecificity. shRNAs, driven by Pol III
promoter (human H1 promoter or human U6 promoter),
inhibited the expression of target genes (cAxin2, cParaxis)
in chicken embryos. The EGFP signal indicated the trans-
fected area. It facilitated analysis of gene silencing in the
transfected region after electroporation and re-incubation of
F. Dai et al. / Developmental Biology 285 (2005) 80–90 89the chicken embryos. The effects of RNAi on the expression
of target genes were examined by in situ hybridization after
the EGFP signals were documented. The result analysis
showed that the RNAi effects correlated to cells or tissues
with EGFP expression. This novel dual expression EGFP–
shRNA system and chicken embryonic model opens new
possibilities to study gene function in a convenient and
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